CARDIOVASCULAR RISK ASSESSMENT IN PEOPLE LIVING WITH TYPE 1 DIABETES FROM THE RENACED-DT1 MEXICAN REGISTRY

被引:0
|
作者
Almeda-Valdes, P. [1 ]
Antonio-Villa, N. [2 ]
Garcia-Tuomola, A. [3 ]
Vidrio-Velazquez, M. [4 ]
Islas-Ortega, L. [5 ]
Bustamante-Martinez, J. [6 ]
Martinez-Ramos Mendez, A. [7 ]
De la Garza-Hernandez, N. [8 ]
Gonzalez-Galvez, G. [9 ]
Valadez-Capetillo, M. [10 ]
Sanchez-Ruiz, K. [11 ]
Castillo-Galindo, C. [12 ]
Yepez-Rodriguez, A. [13 ]
Polanco-Preza, M. [14 ]
Faradji, R. [15 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Metab Dis Res Unit, Endocrinol & Metab, Mexico City, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Med, Md Phd Pecem Program, Mexico City, DF, Mexico
[3] Ctr Med ABC, Endocrinol, Mexico City, DF, Mexico
[4] Unidad Invest Cardiometab Occidente, Endocrinol, Guadalajara, Jalisco, Mexico
[5] Hosp Nino DIF Hidalgo, Endocrinol, Hidalgo, Mexico
[6] Clin DIME, Endocrinol, Nayarit, Mexico
[7] Clin Roma, Endocrinol, Mexico City, DF, Mexico
[8] CEMEDIN, Endocrinol, Monterrey, Mexico
[9] Inst Jalisciense Invest Diabet & Obesidad SC, Endocrinol, Guadalajara, Mexico
[10] Hosp Especialidades Nino & La Mujer, Endocrinol, Queretaro, Mexico
[11] Clin Diabet, Endocrinol, Durango, Mexico
[12] Clin EnDi, Endocrinol, Mexico City, DF, Mexico
[13] Corp Hosp Satelite, Internal Med & Endocrinol, Mexico City, DF, Mexico
[14] Hosp Civil Guadalajara Fray Antonio Alcalde, Endocrinol, Guadalajara, Mexico
[15] Clin EnDi, Endocrinol, Mexico City, DF, Mexico
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EP101 / #7
引用
收藏
页码:A123 / A123
页数:1
相关论文
共 50 条
  • [21] Cardiovascular Risk in Type 1 Diabetes Mellitus
    Jonathan Schofield
    Jan Ho
    Handrean Soran
    [J]. Diabetes Therapy, 2019, 10 : 773 - 789
  • [22] Type 1 diabetes mellitus and cardiovascular risk
    Jose Chillaron, Juan
    Francisco Cano, Juan
    Pedro-Botet, Juan
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (05): : 210 - 217
  • [24] Cardiovascular Risk Management in Type 1 Diabetes
    Teoh, I. H.
    Elisaus, P.
    Schofield, J. D.
    [J]. CURRENT DIABETES REPORTS, 2021, 21 (09)
  • [25] Cardiovascular disease risk in type 1 diabetes
    Anagnostis, Panagiotis
    Godsland, Ian F.
    [J]. Lancet Diabetes & Endocrinology, 2015, 3 (05): : 316 - 317
  • [26] Cardiovascular Risk Management in Type 1 Diabetes
    I. H. Teoh
    P. Elisaus
    J. D. Schofield
    [J]. Current Diabetes Reports, 2021, 21
  • [27] Overweight and Obesity in People Living With Type 1 Diabetes: A Cross-Sectional Analysis of the BETTER Registry
    Lalanne-Mistrih, Marie-Laure
    Bonhoure, Anne
    Messier, Virginie
    Boudreau, Valerie
    Lebbar, Maha
    Talbo, Meryem K.
    Sun, Cathy J.
    Bandini, Aude
    Secours, Laurence
    Calderon, Virginie
    Grou, Caroline
    Tressieres, Benoit
    Brazeau, Anne-Sophie
    Rabasa-Lhoret, Remi
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (06)
  • [28] Glycaemic risk assessment in children and young people with Type 1 diabetes mellitus
    Hill, N. R.
    Thompson, B.
    Bruce, J.
    Matthews, D. R.
    Hindmarsh, P.
    [J]. DIABETIC MEDICINE, 2009, 26 (07) : 740 - 743
  • [29] Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
    Varkevisser, Rita Delphine Maiko
    Birnie, Erwin
    Vollenbrock, Charlotte E.
    Mul, Dick
    van Dijk, Peter R.
    van der Klauw, Melanie M.
    Veeze, Henk
    Wolffenbuttel, Bruce H. R.
    Aanstoot, Henk-Jan
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (04)
  • [30] An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes
    O'Neal, David N.
    Cohen, Ohad
    Vogrin, Sara
    Vigersky, Robert A.
    Jenkins, Alicia J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (02) : 108 - 115